CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Item 12
- 8-K Event Item 5
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- S-3 Offering Registration Statement
- 8-K Event Item 5 · Item 7
- 8-K Event Item 7 · Item 9
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- REGDEX Other REGDEX
- 8-K Event Item 5 · Item 7
- 8-K Event Item 5 · Item 7
- 4 Insider Changes in Ownership
- 8-A12G Other 8-A12G
- 8-K Event Item 5 · Item 7
Page 63 of 69 · 1,379 filings